Media Coverage

Media Coverage

Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.

Pharma's almanac logo image
Looking Beyond Current Treatments for CNS Diseases and Disorders
Read
BioWorld logo image
Going all the way, NMDA work sped up as chances weighed for big players
Read
Applied Clinical Trials logo image
Nasal Spray Research Moves to Social Anxiety Disorder
Read
Thrive Global logo image
The Future of Healthcare: “Let’s focus on a new generation of treatment options for major depressive disorder, social anxiety disorder and suicidal ideation.”
Read
Medium logo image
The Future of Healthcare: “Let’s focus on a new generation of treatment options for major depressive disorder, social anxiety disorder and suicidal ideation.”
Read
PharmaExec.com logo image
Ketamine-Like Compound Offers New Hope as a Potential Antidepressant and Non-opioid Painkiller
Read
BioWorld logo image
FDA clears J&J's esketamine in treatment-resistant depression, with restrictions as per REMS
Read
Fox Business logo image
J&J's ketamine-based drug drives sea change for new depression treatments
Read
Cheddar logo image
Seeking a Cure: VistaGen Therapeutics' Potential Anti-Depression Drug
Read